Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2023-04-11 2023-02-08
Drug Identification Number 02404044 02404044
Brand name XERESE XERESE
Common or Proper name XERESE XERESE
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients HYDROCORTISONE ACYCLOVIR HYDROCORTISONE ACYCLOVIR
Strength(s) 1% 5% 1% 5%
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL TOPICAL TOPICAL
Packaging size 5g 5g
ATC code D06BB D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date 2023-04-21 2023-04-21
Actual start date
Estimated end date 2023-06-13 2023-06-13
Actual end date 2023-04-07
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments